Cargando…
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation frequency on lung adenocarcinoma is still limited to retrospective studies. The PIONEER study (NCT01185314) is a prospective mo...
Autores principales: | Shi, Yuankai, Li, Junling, Zhang, Shucai, Wang, Mengzhao, Yang, Shujun, Li, Ning, Wu, Gang, Liu, Wei, Liao, Guoqing, Cai, Kaican, Chen, Liang’an, Zheng, Meizhen, Yu, Ping, Wang, Xiuwen, Liu, Yunpeng, Guo, Qisen, Nie, Ligong, Liu, Jiwei, Han, Xiaohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657882/ https://www.ncbi.nlm.nih.gov/pubmed/26599344 http://dx.doi.org/10.1371/journal.pone.0143515 |
Ejemplares similares
-
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
por: Shi, Yuankai, et al.
Publicado: (2014) -
Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review
por: Yu, Qiaowen, et al.
Publicado: (2015) -
The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005–2020): A systematic review
por: Chen, Haizhu, et al.
Publicado: (2021) -
Hyper-IgE Syndrome with STAT3 Mutation: A Case Report in Mainland China
por: Xie, Lixin, et al.
Publicado: (2010) -
The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020
por: Zhong, Qiaofeng, et al.
Publicado: (2021)